About
Christin Glorioso is an MIT-trained neuroscientist, physician, and entrepreneur focused on brain aging and dementia prevention. She is CEO and co-founder of NeuroAge Therapeutics, a longevity techbio company developing brain-aging diagnostics and therapeutics. She also founded and leads Longevity Global, a nonprofit community connecting researchers, entrepreneurs, and investors in longevity.
Areas of interest
longevitybiotechbrain agingAlzheimer's diseasedementianeuroscienceAIcomputational biologydiagnosticstherapeuticsepidemiologypublic healthcommunity building